Shorter blood thinner after hip replacement: a recovery study
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a shorter course of blood thinner medication (rivaroxaban) after hip replacement surgery, following an enhanced recovery plan. It aims to see if a shorter treatment can safely prevent blood clots and help you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You are scheduled to have a planned first-time hip replacement surgery.
- You are able to walk and get up from a chair quickly (Timed Up and Go test under 20 seconds).
- You are not severely overweight (BMI under 40).
- You do not have serious kidney or liver disease, active cancer, or a history of blood clots.
- You are not already taking long-term blood thinners (except low-dose aspirin or clopidogrel).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
This trial tests whether a combination of two blood thinners (rivaroxaban and aspirin) is better than aspirin alone at preventing clots after hip fracture surgery, for people who also had a mild heart injury. It may help find a safer, more effective way to prevent dangerous blood clots.
This trial compares a new blood thinner called REGN7508 to two standard blood thinners (apixaban and enoxaparin) to prevent blood clots after total knee replacement surgery. The goal is to see which is safer and more effective.
This trial studies which pill regimen helps prevent dangerous blood clots after hip fracture surgery. You might be eligible if you’re 50 or older and can start treatment soon after your injury.
This trial tests a blood thinner called rivaroxaban (Xarelto) given right after heart valve surgery with a tissue valve. It aims to see if it can prevent blood clots or strokes safely in the early recovery period.
Hear when a new Hip Arthroplasty, Total trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.